Senior Director
Cellectis
Senior Director
Cellectis
Develops allogeneic CAR-T cell therapies
POSITION SUMMARY
The Senior Director, Statistics will be in charge of the development and oversight of biostatistics and statistical/clinical programming strategies, operations, and personnel to ensure the efficient, accurate and timely collection and analysis of clinical trial data while ensuring high standards of data integrity and quality. The Senior Director Biostatistics will partner with other company leaders to design and implement clinical development plans, and overall development strategy for Cellectis’ programs and products. The incumbent will manage and direct CRO partners and leverage the capabilities of these partners. This role is an experienced leader comfortable liaising with senior levels of management both within and external to the organization.
POSITION RESPONSIBILITIES
EDUCATION AND EXPERIENCE
CORE COMPETENCIES
PHYSICAL REQUIREMENTS
Anticipated compensation, DOE, $220,000 - $240,000
Cellectis develops immunotherapy treatments for cancer using gene-edited allogeneic CAR T cells. Its products rely on donor-derived T cells that are edited to remove T cell receptor activity and engineered to express a chimeric antigen receptor (CAR) that targets cancer cells. The goal is to create off-the-shelf CAR T therapies that are available quickly and at a lower cost than patient-specific (autologous) CAR T treatments. Cellectis works through research and development, clinical trials, and partnerships with other pharma companies, such as Sanofi, and generates revenue from licensing, milestone payments, and potential future product sales. The company differentiates itself by offering off-the-shelf solutions rather than custom-made therapies, aiming to broaden access to advanced cancer treatment.
Explore more opportunities at Cellectis